Hera Biotech, a San Antonio-based startup developing a nonsurgical diagnostic test for endometriosis, won the Pitch Perfect contest at MedCity News’ INVEST Digital Health conference. The average diagnostic delay for the endometriosis is eight years, driven in large part by the fact that the only method currently used to diagnose the disease is a surgical procedure.
Industry executives will share their insights at the INVEST Pop Health conference, held in collaboration with New Orleans Business Alliance, scheduled for November 15-16.